[Summary] Bringing innovative and differentiated oncology therapies to cancer pa
Founded in late 2015, CStone Pharmaceuticals (HKEX stock code: 2616) is an innovation-driven biopharmaceutical company focusing on the research and development of drugs in key disease areas such as oncology, autoimmune and inflammatory diseases, and is committed to meeting the urgent medical needs of patients in China and worldwide. To date, the company has successfully launched 4 innovative drugs, with 16 New Drug Applications (NDAs) approved and 9 indications approved. The current pipeline consists of a balanced portfolio of 16 drug candidates, including potential first-in-class or best-in-class antibody-drug conjugates (ADCs), multi-specific antibodies, immuno-oncology therapies and precision medicines. Meanwhile, CStone Pharmaceuticals has a seasoned management team with full-chain coverage of key functions including preclinical discovery, clinical translation, clinical development, drug manufacturing, business development and commercial operations.
What does CStone Pharmaceuticals (Suzhou) Co., Ltd. require? Who is CStone Pharmaceuticals hiring? CStone Pharmaceuticals recruitment: 医疗卫生/美容保健类占比最多占59.3%,其次是经营管理类占33.3%. What education can get in at CStone Pharmaceuticals? 本科占比最多占51.9%,其次是硕士占37%. High education required at CStone Pharmaceuticals? 硕士占37%,博士占7.4%. Work experience required at CStone Pharmaceuticals? 5-10年占比最多占40.7%,其次是3-5年占25.9%. Where are the job locations at CStone Pharmaceuticals? 上海占比最多占63%,其次是苏州占14.8%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows